The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals

Journal of Hospital Infection

Volumn 65, Issue SUPPL. 2, 2007, Pages 73-81

  MacKenzie, Fiona M ^a   Gould, Ian M ^a   Bruce, Julie ^b   Mollison, Jill ^b   Monnet, Dominique L ^c   Krcmery, Vladimir ^d   Cookson, Barry ^e   van der Meer, Jos W M ^f  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

^d St Elisabeth Cancer Institute   (Slovakia)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic; Europe; Microbiology; Pharmacy; Stewardship

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; DRUG USE; EASTERN EUROPE; EUROPE; GEOGRAPHY; HOSPITAL BED UTILIZATION; HOSPITAL CARE; HOSPITAL DEPARTMENT; HOSPITAL PHARMACY; HOSPITAL POLICY; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; WESTERN EUROPE;

ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; EUROPE; EUROPE, EASTERN; FORMULARIES, HOSPITAL; HOSPITALS; HUMANS; INFECTION CONTROL PRACTITIONERS; LABORATORIES, HOSPITAL; MICROBIOLOGY; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL ROLE;

EID: 34249304396     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(07)60019-X     Document Type: Article

References (21)

1. Cunney R., and Smyth E. The impact of laboratory reporting practice on antibiotic utilisation. Int J Antimicrob Agents 14 (2000) 13-19
2. Monnet D., MacKenzie F., Lopez-Lozano J., et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen 1996 2000. Emerg Infect Dis 10 (2004) 1432-1441
3. MacKenzie F., Struelens M., Towner K., Gould I., and on behalf of the ARPAC Steering Group and the ARPAC Consensus Conference Participants. Report of the consensus conference on antibiotic resistance; prevention and control (ARPAC). Clin Microbiol Infect 11 (2005) 737-754
4. Copenhagen recommendations. Report from the Invitational EU Conference on the Microbial Threat (1998), Ministry of Health, Ministry of Food, Agriculture and Fisheries, Copenhagen, Denmark
5. Knox K., Lawson W., and Holmes A. Multidisciplinary antimicrobial management teams and the role of the pharmacist in management of infection. In: Gould I., and Van Der Meer J. (Eds). Antibiotic Policies: Theory and Practice (2004), Kluwer Academic/Plenum Publishers, New York 227-249
6. MacKenzie F., Monnet D., Gould I., and on behalf of the ARPAC Steering Group. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 58 (2006) 657-660
7. World Population Datasheet (2004), Population Reference Bureau, Washington, DC 11-13
8. Struelens M., Wagner D., Bruce J., et al., on behalf of the ARPAC Steering Group. Status of infection control policies and organisation in European hospitals, 2001: the ARPAC study. Clin Microbiol Infect 12 (2006) 729-737
9. MacKenzie F., Bruce J., Struelens M., Mollison J., Gould I., and on behalf of the ARPAC Steering Group. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in European hospitals. Clin Microbiol Infect 13 (2007) 269-276
10. MacKenzie F., Bruce J., Van Looveren M., Cornaglia G., Gould I., Goossens H., and the ARPAC Steering Group. Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study. Clin Microbiol Infect 12 (2006) 1185-1192
11. Davey P., Brown E., Fenelon L., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 4. doi:10.1002/14651858.CD003543.pub2
12. Gould I. Antibiotic policies and control of resistance. Curr Opin Infect Dis 15 (2002) 395-400
13. Gould I., and Van Der Meer J. Audits for monitoring the quality of antimicrobial prescriptions. Antibiot Pol Theor Pract 12 (2004) 197-226
14. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2005. Bilthoven, The Netherlands: National Institute for Public Health and the Environment.
15. Trenholme G., Kaplan R., Karakusis P., et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood cultures isolates. J Clin Microbiol 27 (1989) 1342-1345
16. Barenfanger J., Drake C., and Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37 (1999) 1415-1418
17. Doern G., Vautour R., Gaudet M., and Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32 (1994) 1757-1762
18. Cunney R., Abdel Aziz H., Schubert D., McNamara E., and Smyth E. Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. J Antimicrob Chemother 45 (2000) 705-708
19. Gould I., and MacKenzie F. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. Symp Ser Soc Appl Microbiol 31 (2002) 78S-84S
20. Gould I., and Van Der Meer J. Interventions to optimise antibiotic prescribing in hospitals: The UK approach. Antibiot Pol Theor Pract 10 (2004) 159-183
21. Evans R., Pestotnik S., Classen D., et al. A computerassisted management program for antibiotics and other antiinfective agents. N Engl J Med 338 (1998) 232-238